イワサキ マサユキ
Iwasaki Masayuki
岩崎 正幸 所属 研究施設 研究施設 職種 講師 |
|
論文種別 | 原著 |
言語種別 | 英語 |
査読の有無 | 査読あり |
表題 | Next-generation NAMPT inhibitors identified by sequential high-throughput phenotypic chemical and functional genomic screens. |
掲載誌名 | 正式名:Chemistry & biology 略 称:Chem Biol ISSNコード:18791301/10745521 |
掲載区分 | 国外 |
巻・号・頁 | 20(11),pp.1352-63 |
著者・共著者 | Matheny Christina J, Wei Michael C, Bassik Michael C, Donnelly Alicia J, Kampmann Martin, Iwasaki Masayuki, Piloto Obdulio, Solow-Cordero David E, Bouley Donna M, Rau Rachel, Brown Patrick, McManus Michael T, Weissman Jonathan S, Cleary Michael L |
発行年月 | 2013/11 |
概要 | Phenotypic high-throughput chemical screens allow for discovery of small molecules that modulate complex phenotypes and provide lead compounds for novel therapies; however, identification of the mechanistically relevant targets remains a major experimental challenge. We report the application of sequential unbiased high-throughput chemical and ultracomplex small hairpin RNA (shRNA) screens to identify a distinctive class of inhibitors that target nicotinamide phosphoribosyl transferase (NAMPT), a rate-limiting enzyme in the biosynthesis of nicotinamide adenine dinucleotide, a crucial cofactor in many biochemical processes. The lead compound STF-118804 is a highly specific NAMPT inhibitor, improves survival in an orthotopic xenotransplant model of high-risk acute lymphoblastic leukemia, and targets leukemia stem cells. Tandem high-throughput screening using chemical and ultracomplex shRNA libraries, therefore, provides a rapid chemical genetics approach for seamless progression from small-molecule lead identification to target discovery and validation. |
DOI | 10.1016/j.chembiol.2013.09.014 |
PMID | 24183972 |